AI Agent Operational Lift for Aqua in Greenfield, Indiana

Why AI matters at this scale

Elanco Aqua, a division of Elanco Animal Health, operates at the intersection of pharmaceuticals and global protein production. With 5,001-10,000 employees and an estimated annual revenue exceeding $1 billion, the company is a dominant force in aquaculture health, providing vaccines, anti-infectives, and parasiticides to fish and shrimp farmers worldwide. At this scale, the organization generates immense volumes of data—from clinical trials and pharmacovigilance to farm-level environmental and production metrics. AI is no longer optional; it is the critical lever to transform this data into predictive insights, operational efficiency, and differentiated customer value, directly addressing the industry's pressures of sustainability, antibiotic reduction, and food security.

1. Predictive Disease & Mortality Analytics

The highest-impact AI opportunity lies in predictive health. Aquaculture operations lose billions annually to preventable disease outbreaks. By integrating Elanco's proprietary health data with real-time farm sensor data (oxygen, temperature, biomass), a machine learning platform can forecast disease events days before clinical signs appear. This allows farmers to apply targeted treatments, reducing mortality by an estimated 20-50% and slashing broad-spectrum antibiotic use. The ROI is immediate: a single avoided outbreak on a medium-sized salmon farm can save over $2 million. For Elanco, this transforms the business model from selling treatments to selling guaranteed health outcomes.

2. Precision Feeding via Computer Vision

Feed constitutes up to 60% of aquaculture production costs, and overfeeding pollutes water while underfeeding stunts growth. Deploying AI-powered computer vision above and below water can analyze fish appetite, size distribution, and swimming behavior in real-time to automate optimal feeding. Reinforcement learning algorithms continuously adapt to changing conditions, improving the Feed Conversion Ratio (FCR) by 5-10%. For a large shrimp farm, this translates to hundreds of thousands in annual feed savings and a significantly lower environmental footprint, aligning perfectly with Elanco's sustainability commitments.

3. Generative AI for Regulatory & Veterinary Support

Bringing a new aquatic pharmaceutical to market involves navigating complex, multi-country regulatory frameworks. A generative AI tool, fine-tuned on Elanco's internal archives of successful submissions and global regulations, can draft initial reports, summarize preclinical data, and ensure compliance consistency. This could accelerate dossier preparation by 30-40%. Simultaneously, a GenAI-powered veterinary assistant, accessible via mobile, can provide field technicians with instant, evidence-based diagnostic and treatment recommendations, amplifying the expertise of Elanco's global workforce and improving on-farm decision quality.

Deployment Risks for a 5001-10000 Employee Enterprise

Implementing AI at this scale carries specific risks. Data silos between R&D, manufacturing, and commercial divisions can cripple model development. Regulatory scrutiny from the FDA and EMA on AI-driven decisions in animal health requires rigorous validation and explainability. Change management is paramount; field veterinarians and farmers may distrust algorithmic recommendations without transparent reasoning. Finally, the cost of building and maintaining a specialized AI infrastructure demands a clear, phased strategy with executive sponsorship to avoid pilot purgatory and ensure enterprise-wide adoption.